Malaysian Genomics Resource (0155) - Total Liabilities

Latest as of December 2025: RM2.94 Million MYR ≈ $736.88K USD

Based on the latest financial reports, Malaysian Genomics Resource (0155) has total liabilities worth RM2.94 Million MYR (≈ $736.88K USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore cash efficiency ratio of Malaysian Genomics Resource to assess how effectively this company generates cash.

Malaysian Genomics Resource - Total Liabilities Trend (2015–2025)

This chart illustrates how Malaysian Genomics Resource's total liabilities have evolved over time, based on quarterly financial data. See what is Malaysian Genomics Resource's book value for net asset value and shareholders' equity analysis.

Malaysian Genomics Resource Competitors by Total Liabilities

The table below lists competitors of Malaysian Genomics Resource ranked by their total liabilities.

Company	Country	Total Liabilities
Titan Logix Corp. V:TLA	Canada	CA$1.14 Million
Alpha Modus Holdings, Inc NASDAQ:AMOD	USA	$10.80 Million
Mint Incorporation Limited Class A Ordinary Shares NASDAQ:MIMI	USA	$1.78 Million
LCK Global Kedaton JK:LCKM	Indonesia	Rp7.14 Billion
Baru Gold Corp V:BARU	Canada	CA$8.91 Million
Onelife Capital Advisors Limited NSE:ONELIFECAP	India	Rs1.34 Billion
CLASS 1 NICKEL+TECH.LTD F:77C	Germany	€2.84 Million
Sahathai Terminal Public Company Limited BK:PORT	Thailand	฿1.74 Billion

Liability Composition Analysis (2015–2025)

This chart breaks down Malaysian Genomics Resource's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 0155 stock market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	3.18	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.19	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.16	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Malaysian Genomics Resource's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Malaysian Genomics Resource (2015–2025)

The table below shows the annual total liabilities of Malaysian Genomics Resource from 2015 to 2025.

Year	Total Liabilities	Change
2025-06-30	RM4.20 Million ≈ $1.05 Million	+25.12%
2024-06-30	RM3.36 Million ≈ $842.77K	-17.81%
2023-06-30	RM4.08 Million ≈ $1.03 Million	-15.67%
2022-06-30	RM4.84 Million ≈ $1.22 Million	-0.20%
2021-06-30	RM4.85 Million ≈ $1.22 Million	+486.11%
2020-06-30	RM827.98K ≈ $207.88K	-96.07%
2019-06-30	RM21.07 Million ≈ $5.29 Million	+0.01%
2018-06-30	RM21.07 Million ≈ $5.29 Million	+56.14%
2017-06-30	RM13.49 Million ≈ $3.39 Million	+550.16%
2016-06-30	RM2.08 Million ≈ $521.09K	-48.95%
2015-06-30	RM4.07 Million ≈ $1.02 Million	--

About Malaysian Genomics Resource

KLSE:0155 Malaysia Diagnostics & Research

Market Cap

$9.66 Million

RM38.49 Million MYR

Market Cap Rank

#27103 Global

#856 in Malaysia

Share Price

RM0.26

Change (1 day)

-1.92%

52-Week Range

RM0.17 - RM0.26

All Time High

RM2.72